Zivo Bioscience, Inc.
ZIVO
$17.21
-$0.30-1.71%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 90.00K | 31.50K | -- | 35.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 90.00K | 31.50K | -- | 35.70K |
| Cost of Revenue | -- | 63.00K | 22.10K | -- | 23.20K |
| Gross Profit | -- | 27.00K | 9.50K | -- | 12.50K |
| SG&A Expenses | 1.44M | 1.38M | 1.94M | 5.98M | 975.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.21M | 1.69M | 2.29M | 8.23M | 1.31M |
| Operating Income | -4.21M | -1.60M | -2.26M | -8.23M | -1.28M |
| Income Before Tax | -4.21M | -1.60M | -2.27M | -8.24M | -1.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.21M | -1.60M | -2.27M | -8.24M | -1.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.21M | -1.60M | -2.27M | -8.24M | -1.28M |
| EBIT | -4.21M | -1.60M | -2.26M | -8.23M | -1.28M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.12 | -0.45 | -0.67 | -2.78 | -0.47 |
| Normalized Basic EPS | -0.70 | -0.28 | -0.42 | -1.74 | -0.29 |
| EPS Diluted | -1.12 | -0.45 | -0.67 | -2.78 | -0.47 |
| Normalized Diluted EPS | -0.70 | -0.28 | -0.42 | -1.74 | -0.29 |
| Average Basic Shares Outstanding | 3.75M | 3.54M | 3.41M | 2.96M | 2.75M |
| Average Diluted Shares Outstanding | 3.75M | 3.54M | 3.41M | 2.96M | 2.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |